日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Perceptions of stigma of pregnant individuals experiencing substance use disorder receiving prenatal care at magdalene clinic: a cross-sectional study

玛格达琳诊所接受产前护理的患有物质使用障碍的孕妇所面临的污名化认知:一项横断面研究

McKinnon, Hannah F; Fair, Melissa L; Teel, Jody; Lubaczewski, Courtney; Kimura, Alison; Smith, Kimbley; Eichelberger, Kacey

A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia

一项 Ib 期首次人体研究,旨在评估 Ponsegromab 在癌症合并恶病质患者中的安全性、耐受性、药代动力学和药效学。

Crawford, Jeffrey; Calle, Roberto A; Collins, Susie M; Weng, Yan; Lubaczewski, Shannon L; Buckeridge, Clare; Wang, Ellen Q; Harrington, Magdalena A; Tarachandani, Anil; Rossulek, Michelle I; Revkin, James H

Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design

一项评估ponsegromab治疗癌症恶病质患者疗效和安全性的II期研究:PROACC-1研究设计

Groarke, John D; Crawford, Jeffrey; Collins, Susie M; Lubaczewski, Shannon L; Breen, Danna M; Harrington, Magdalena A; Jacobs, Ira; Qiu, Ruolun; Revkin, James; Rossulek, Michelle I; Saxena, Aditi R

A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis

一项 1 期随机、双盲、安慰剂对照、单剂量和多剂量递增研究,旨在评估 PF-06835375(一种靶向 CXC 趋化因子受体 5 型的抗体)在系统性红斑狼疮或类风湿性关节炎患者中的安全性和药代动力学/药效学。

Cohen, Stanley; Beebe, Jean S; Chindalore, Vishala; Guan, Shunjie; Hassan-Zahraee, Mina; Saxena, Madhurima; Xi, Li; Hyde, Craig; Koride, Sarita; Levin, Robert; Lubaczewski, Shannon; Salganik, Mikhail; Sloan, Abigail; Stevens, Erin; Peeva, Elena; Vincent, Michael S; Martin, David A; Chu, Myron

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)

1997-2019 年发现的严重药物不良反应对患者、临床医生和制造商的影响:来自南方不良反应网络 (SONAR) 的定性分析

Bennett, Charles L; Hoque, Shamia; Olivieri, Nancy; Taylor, Matthew A; Aboulafia, David; Lubaczewski, Courtney; Bennett, Andrew C; Vemula, Jay; Schooley, Benjamin; Witherspoon, Bartlett J; Godwin, Ashley C; Ray, Paul S; Yarnold, Paul R; Ausdenmoore, Henry C; Fishman, Marc; Herring, Georgne; Ventrone, Anne; Aldaco, Juan; Hrushesky, William J; Restaino, John; Thomsen, Henrik S; Yarnold, Paul R; Marx, Robert; Migliorati, Cesar; Ruggiero, Salvatore; Nabhan, Chadi; Carson, Kenneth R; McKoy, June M; Yang, Y Tony; Schoen, Martin W; Knopf, Kevin; Martin, Linda; Sartor, Oliver; Rosen, Steven; Smith, William K

Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder

学龄前儿童注意力缺陷/多动障碍的诊断和治疗方案

Wigal, Sharon; Chappell, Phillip; Palumbo, Donna; Lubaczewski, Shannon; Ramaker, Sara; Abbas, Richat